Skip to content

A Feasibility Study of a Novel Glucose Sensor for Continuous Glucose Monitoring in Type 1 Diabetes.

A Feasibility Study Examining the Accuracy and Reliability of a Novel Redundant Electrochemical Sensor (Harmony Sensor) for Continuous Glucose Monitoring in Type 1 Diabetes.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12614000256673
Acronym
Harmony
Enrollment
23
Registered
2014-03-11
Start date
2014-03-17
Completion date
2015-03-08
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Glucose sensor technology has been evolving with an ultimate goal of achieving a level of accuracy required for finger-prick capillary glucose measurement replacement and reliability needed for consistent closed-loop functionality. While there have been recent advances in CGM technology, further improvements relating to sensor accuracy and reliability are required. Glucose sensor redundancy (the incorporation of multiple sensing elements onto a single sensor) represents the next logical step toward the ultimate goal of achieving a level of accuracy and reliability required for a stand-alone glucose monitor and a closed-loop system. The Harmony Sensor represents an advance in electro-chemical sensor design and incorporates a redundant sensor system. The Harmony sensor consists of a unique electro-chemical sensor in a fold-over design, so that there are sensing elements on both planar surfaces. This feasibility study will assess the accuracy and reliability of the redundant electrochemical sensor (Harmony) for CGM compared to YSI values and meter glucose values.

Interventions

The Harmony Sensor represents an advance in electro-chemical sensor design and incorporates a redundant sensor system. Redundancy can be defined as two or more sensing elements utilizing the same or different technologies to measure the same output. The Harmony sensor consists of a unique electro-chemical sensor in a fold-over design, so that there are sensing elements on both planar surfaces. This feasibility study will assess the accuracy and reliability of the redundant electrochemical sensor

The Harmony Sensor represents an advance in electro-chemical sensor design and incorporates a redundant sensor system. Redundancy can be defined as two or more sensing elements utilizing the same or different technologies to measure the same output. The Harmony sensor consists of a unique electro-chemical sensor in a fold-over design, so that there are sensing elements on both planar surfaces. This feasibility study will assess the accuracy and reliability of the redundant electrochemical sensor (Harmony) for Contiuous Glucose Monitoring (CGM) compared to current non-redundant electrochemical sensors. All participants will continuously wear two investigational Harmony glucose sensors for the whole duration of the study (168 hours). Each sensor will be inserted subcutaneously into the abdomen using a dedicated sensor inserter, a procedure which takes under 5 minutes. Both sensors are attached to a glucose sensor recorder or transmitter which will capture all sensor related information and be uploaded at the conclusion of the study. The participant will follow the following schedule: Visit 1 (Day 1): Both sensors will be inserted. Devise training will be provided to the participants. Finger-prick capillary glucose will be performed via study glucose meter at 30 minute intervals for half-an-hour prior to and 3 hours post sensor insertion (first 15 participants), and at 30 minute intervals from half-an-hour to 3 hours post sensor insertion (last 15 participants). Visit 2 (Day 4): 72 hours post insertion of the sensors, participants will return to clinical trial centre (CTC) to perform a meal test. A standardised test meal containing 65g carbohydrate will be consumed by each participant. Venous blood samples will be collected at 15 minute intervals for half-an-hour prior to and 3 hours post meal ingestion, to be used for glucose measurement by YSI and study glucose meter. Visit 3 (Day 8): 168 hours post insertion of the sensors, participants will return CTC to perform a final meal test. A standardised test meal containing 65g carbohydrate will be consumed by each participant. Venous blood samples will be collected at 15 minute intervals for half-an-hour prior to and 3 hours post meal ingestion, to be used for glucose measurement by YSI and study glucose meter. Between the visits, participants will be instructed to perform finger-prick glucose levels a minimum of 8 times a day (pre-meals and 2 hours post meals) which wil be recorded on the study glucose meter history. Data from study devices will not impact upon decisions involving care of the participants as sensor generated glucose data will not be available to the participants.

Sponsors

St Vincent's Hospital, Melbourne
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
21 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Participant is 21-70 years of age at time of screening. 2. A clinical diagnosis of type 1 diabetes, as determined by the Investigator. 3. Participant is using insulin to treat his/her diabetes. 4. Currently using a sensor or has experience with sensor use. 5. Preference will be given to subjects who have a history of hypoglycaemia 6. Participant is willing to comply with all requirements associated with the protocol.

Exclusion criteria

1. Participant has a positive pregnancy screening test 2. Participant is female and plans to become pregnant during the course of the study. 3. Participant is unable to tolerate tape adhesive in the area of sensor placement. 4. Participant has any unresolved adverse skin condition in the area of sensor or device placement (e.g., psoriasis, rash, Staphylococcus infection).

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026